サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：色素沈着障害治療の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1180749

色素沈着障害治療の世界市場 - 成長、将来展望、競合分析（2022年～2030年）

Pigmentation Disorders Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
色素沈着障害治療の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年11月30日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の色素沈着障害治療の市場規模は、2021年の67億7,740万米ドルから、2030年までに123億1,320万米ドルに達し、2022年から2030年の予測期間中に6.9％のCAGRで成長すると予測されています。

当レポートでは、世界の色素沈着障害治療市場について調査し、市場動向、競合情報、セグメント分析、新興動向、技術分析、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

  • レポート概要
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の色素沈着障害治療市場
  • 世界の色素沈着障害治療市場：治療別（2021年）
  • 世界の色素沈着障害治療市場：疾患別（2021年）
  • 世界の色素沈着障害治療市場：地域別（2021年）
  • 魅力的な投資提案：地域別（2021年）

第3章 色素沈着障害治療市場：競合分析

  • 主要な色素沈着障害治療市場ベンダーの市場ポジショニング
  • 色素沈着障害治療市場ベンダーの採用戦略
  • 主要な業界戦略
  • 階層分析：2021年対2030年

第4章 色素沈着障害治療市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の色素沈着障害治療市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 色素沈着障害治療市場：治療別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • 外用薬
    • ケミカルピーリング
    • マイクロダーマブレーション
    • 光線療法
    • レーザー治療

第6章 色素沈着障害治療市場：疾患別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • 肝斑
    • 白皮症
    • 白斑
    • 炎症後色素沈着
    • その他（日光黒子、尋常性ざ瘡など）

第7章 北米の色素沈着障害治療市場（2020年～2030年）

  • 市場概要
  • 色素沈着障害治療市場：治療別（2020年～2030年）
  • 色素沈着障害治療市場：疾患別（2020年～2030年）
  • 色素沈着障害治療市場：地域別（2020年～2030年）
    • 北米

第8章 英国・欧州連合の色素沈着障害治療市場（2020年～2030年）

  • 市場概要
  • 色素沈着障害治療市場：治療別（2020年～2030年）
  • 色素沈着障害治療市場：疾患別（2020年～2030年）
  • 色素沈着障害治療市場：地域別（2020年～2030年）
    • 英国・欧州連合

第9章 アジア太平洋の色素沈着障害治療市場（2020年～2030年）

  • 市場概要
  • 色素沈着障害治療市場：治療別（2020年～2030年）
  • 色素沈着障害治療市場：疾患別（2020年～2030年）
  • 色素沈着障害治療市場：地域別（2020年～2030年）
    • アジア太平洋

第10章 ラテンアメリカの色素沈着障害治療市場（2020年～2030年）

  • 市場概要
  • 色素沈着障害治療市場：治療別（2020年～2030年）
  • 色素沈着障害治療市場：疾患別（2020年～2030年）
  • 色素沈着障害治療市場：地域別（2020年～2030年）
    • ラテンアメリカ

第11章 中東・アフリカの色素沈着障害治療市場（2020年～2030年）

  • 市場概要
  • 色素沈着障害治療市場：治療別（2020年～2030年）
  • 色素沈着障害治療市場：疾患別（2020年～2030年）
  • 色素沈着障害治療市場：地域別（2020年～2030年）
    • 中東・アフリカ

第12章 企業プロファイル

  • ALLERGAN PLC
  • Bayer AG
  • Galderma S.A.
  • EpiPharm AG
  • Pierre Fabre Laboratories
  • La Roche-Posay Laboratoire Pharmaceutique
  • Obagi Cosmeceuticals LLC
  • RXi Pharmaceuticals Corporation
  • SkinCeuticals, Inc.
  • Vivier Pharma, Inc.
図表

List of Tables

  • TABLE 1 Global Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 2 Global Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 3 North America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 4 North America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 5 U.S. Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 6 U.S. Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 7 Canada Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 8 Canada Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 13 UK Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 14 UK Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 15 Germany Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 16 Germany Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 17 Spain Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 18 Spain Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 19 Italy Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 20 Italy Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 21 France Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 22 France Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 25 Asia Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 26 Asia Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 27 China Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 28 China Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 29 Japan Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 30 Japan Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 31 India Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 32 India Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 33 Australia Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 34 Australia Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 35 South Korea Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 36 South Korea Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 37 Latin America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 38 Latin America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 39 Brazil Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 40 Brazil Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 41 Mexico Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 42 Mexico Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 47 GCC Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 48 GCC Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 49 Africa Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 50 Africa Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Pigmentation Disorders Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Pigmentation Disorders Treatment Market: Quality Assurance
  • FIG. 5 Global Pigmentation Disorders Treatment Market, By Treatment, 2021
  • FIG. 6 Global Pigmentation Disorders Treatment Market, By Disease, 2021
  • FIG. 7 Global Pigmentation Disorders Treatment Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Pigmentation Disorders Treatment Market, 2021
  • FIG. 9 Market Positioning of Key Pigmentation Disorders Treatment Market Players, 2021
  • FIG. 10 Global Pigmentation Disorders Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Pigmentation Disorders Treatment Market, By Treatment, 2021 Vs 2030, %
  • FIG. 12 Global Pigmentation Disorders Treatment Market, By Disease, 2021 Vs 2030, %
  • FIG. 13 U.S. Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 France Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 China Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 India Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
目次
Product Code: 138244-08-22

Industry Outlook

The pigmentation disorders treatment market is set to reach US$ 12,313.2 Mn by 2030 from US$ 6,777.4 Mn in 2021 showcasing a steady growth at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2022 to 2030. The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) claims that 1 in 17,000 people suffer with some form of Albinism. Vitiligo is a lifelong condition and there is no permanent cure; however, exposure to UVA and UVB phototherapy stimulates the growth of melanocytes on the skin patches and treats hypopigmentation to a certain extent. In the present scenario, pharmaceutical manufacturers are using topical creams in combination such as adapalene/benzoylperoxide, adapalene/clindamycin for the treatment of face dark spots created due to acne vulgaris. Currently, imiquimod cream (MEDA Pharma GmbH & Co. KG) is in phase 3 clinical trials being tested for better clinical outcomes in the treatment of Solar Lentigines.

North America currently dominates the pigmentation disorders market on account of growing melasma incidence in pregnant women. Existence of well-developed healthcare infrastructure and presence of major players prove beneficial in treating patients suffering with post inflammatory hyperpigmentation in North America. The pigmentation disorders treatment market is growing at a rapid pace in Asia Pacific on account of key drivers such as competition exerted by local manufacturers. The other factors promoting growth are supportive regulatory norms favoring growth of topical drugs, and rise in per capita income.

Rising incidence of skin hyperpigmentation to cater excellent growth for topical drugs

In the current scenario, topical drugs are dominating the treatment type segment owing to better clinical outcomes in patients suffering with pigmentation disorders. The topical drugs commonly prescribed throughout the globe are azelaic acid, hydroquinone, L-ascorbic acid etc. Chemical peels have found prominence in the last 2 decades to treat facial hyperpigmentation disorders. They are effective in treating face wrinkles caused due to aging and harmful sun light, improve the appearance of mild scars and treat dark spots caused due to acne. Dermabrasion has developed a niche market owing to its popularity in solving facial defects such as pox scars, accident scars, age spots and dull skin. Rise in per capita income and upgraded lifestyle are the driving factors for the growth of phototherapy and laser therapy for treating pigmentation disorders. However the high costs associated with photo and laser therapy is a limitation for its market growth.

Higher incidence of melasma in women post pregnancy will result in impressive double-digit growth

Melasma often known as chloasma occurs in 90% of the pregnant women. It results in discoloration of the skin in patches usually in the forearms, chin, cheeks, bridge of the nose and forehead. The incidence of melasma is higher in dark skinned people, in comparison to fair skinned people. The chief factors responsible for the occurrence of melasma in women are hormones, pregnancy and use of birth control pills. Melasma results in huge demand for topical drugs, chemical peels and microdermabrasion for dermal treatment. Post inflammatory hyperpigmentation is set to register growth at a rapid pace due to key factors such as increasing number of domestic accidents resulting in dermal burns and skin tissue abrasion, resulting in hyperpigmentation due to excess melanin production during healing process.

Increasing competition from local players in Asia Pacific will result in tremendous growth during the forecast period

North America accounts for 42% of the market share and thus dominates the global pigmentation disorders treatment market. The important parameters responsible for the burgeoning growth of North America is the presence of market leaders pioneering in dermatology products such as Galderma S.A., RXi Pharmaceuticals Corporation and Vivier Pharma. Rising number of patients suffering with skin pigmentation disorders due to harmful exposure to UV radiation and increasing public awareness related to skin diseases propels the pigmentation disorders treatment market growth in Europe. Asia Pacific is set to register faster growth owing to the competition created by local players. Increase in per capita income and enhanced funding by the pharmaceutical companies in the research and development to enhance the quality and efficacy of dermal products impose a positive effect on the market growth in Asia Pacific.

In order to understand the prevailing market trend and quantitative analysis the market assessment of pigmentation disorders treatment market is performed. Product portfolio is helpful in giving valuable information of the medicines being currently used for the treatment of pigmentation disorders. The major players spearheading the pigmentation disorders treatment market are ALLERGAN, Bayer AG, Galderma S.A., EpiPharm AG, Pierre Fabre Laboratories, La-Roche Posay, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, SkinCeuticals and Vivier Pharma.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pigmentation Disorders Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Pigmentation Disorders Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Market Segmentation

Treatment

Topical Drugs

Chemical Peels

Microdermabrasion

Phototherapy

Laser Therapy

Disease

Melasma

Albinism

Vitiligo

Post-Inflammatory Hyperpigmentation

Others (Solar Lentigines, Acne Vulgaris, etc.)

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Pigmentation Disorders Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Pigmentation Disorders Treatment market?

Which is the largest regional market for Pigmentation Disorders Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Pigmentation Disorders Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Pigmentation Disorders Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Pigmentation Disorders Treatment Market
  • 2.2. Global Pigmentation Disorders Treatment Market, By Treatment, 2021 (US$ Million)
  • 2.3. Global Pigmentation Disorders Treatment Market, By Disease, 2021 (US$ Million)
  • 2.4. Global Pigmentation Disorders Treatment Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Pigmentation Disorders Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Pigmentation Disorders Treatment Market Vendors
  • 3.2. Strategies Adopted by Pigmentation Disorders Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Pigmentation Disorders Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Pigmentation Disorders Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Topical Drugs
    • 5.3.2. Chemical Peels
    • 5.3.3. Microdermabrasion
    • 5.3.4. Phototherapy
    • 5.3.5. Laser Therapy

6. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Melasma
    • 6.3.2. Albinism
    • 6.3.3. Vitiligo
    • 6.3.4. Post-Inflammatory Hyperpigmentation
    • 6.3.5. Others (Solar Lentigines, Acne Vulgaris, etc.)

7. North America Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 7.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
  • 7.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 7.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 7.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 7.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)

8. UK and European Union Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 8.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
  • 8.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 8.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 8.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 8.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 8.4.1.4.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 8.4.1.5.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 8.4.1.6.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)

9. Asia Pacific Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 9.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
  • 9.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 9.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 9.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 9.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 9.4.1.4.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 9.4.1.5.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 9.4.1.6.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)

10. Latin America Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 10.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
  • 10.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 10.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 10.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 10.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)

11. Middle East and Africa Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 11.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
  • 11.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 11.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 11.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
        • 11.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. ALLERGAN PLC
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Bayer AG
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Galderma S.A.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. EpiPharm AG
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Pierre Fabre Laboratories
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. La Roche-Posay Laboratoire Pharmaceutique
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Obagi Cosmeceuticals LLC
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. RXi Pharmaceuticals Corporation
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. SkinCeuticals, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Vivier Pharma, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives